Fmr LLC Pliant Therapeutics, Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 22,210 shares of PLRX stock, worth $35,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,210

Previous 3,876,598 99.43%

Holding current value

$35,091

Previous $51.1 Million 99.94%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$1.35 - $13.53 $5.2 Million - $52.1 Million	-3,854,388 Reduced 99.43%	22,210 $29,000
Q4 2024 Feb 13, 2025	SELL	$10.55 - $15.7 $241,415 - $359,263	-22,883 Reduced 0.59%	3,876,598 $51.1 Million
Q3 2024 Nov 13, 2024	SELL	$10.52 - $14.35 $129,164 - $176,189	-12,278 Reduced 0.31%	3,899,481 $43.7 Million
Q2 2024 Aug 13, 2024	SELL	$10.58 - $15.61 $367,528 - $542,260	-34,738 Reduced 0.88%	3,911,759 $42.1 Million
Q1 2024 May 13, 2024	SELL	$14.14 - $19.59 $239,262 - $331,482	-16,921 Reduced 0.43%	3,946,497 $58.8 Million
Q4 2023 Feb 13, 2024	SELL	$12.85 - $19.15 $2.28 Million - $3.4 Million	-177,586 Reduced 4.29%	3,963,418 $71.8 Million
Q3 2023 Nov 13, 2023	SELL	$14.58 - $20.15 $1.47 Million - $2.04 Million	-101,019 Reduced 2.38%	4,141,004 $71.8 Million
Q2 2023 Aug 11, 2023	SELL	$18.12 - $30.56 $5.25 Million - $8.85 Million	-289,492 Reduced 6.39%	4,242,023 $76.9 Million
Q1 2023 May 11, 2023	BUY	$18.73 - $36.26 $2.59 Million - $5.01 Million	138,284 Added 3.15%	4,531,515 $121 Million
Q4 2022 Feb 13, 2023	SELL	$17.0 - $25.43 $28.8 Million - $43.1 Million	-1,693,262 Reduced 27.82%	4,393,231 $84.9 Million
Q3 2022 Nov 10, 2022	BUY	$7.67 - $24.23 $21 Million - $66.5 Million	2,744,222 Added 82.11%	6,086,493 $127 Million
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $7.12 Million - $15.2 Million	-1,733,054 Reduced 34.15%	3,342,271 $26.8 Million
Q1 2022 May 13, 2022	SELL	$7.01 - $14.1 $2.32 Million - $4.66 Million	-330,524 Reduced 6.11%	5,075,325 $35.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $186,000 - $276,803	15,159 Added 0.28%	5,405,849 $73 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $107,482 - $189,007	6,522 Added 0.12%	5,390,690 $91 Million
Q2 2021 Aug 13, 2021	BUY	$28.05 - $37.69 $151 Million - $203 Million	5,384,168 New	5,384,168 $157 Million

Others Institutions Holding PLRX

# of Institutions

154

Shares Held

62.2M

Call Options Held

279K

Put Options Held

7.1K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $76.9M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account